As of 2025-09-18, the Relative Valuation of TG Therapeutics Inc (TGTX) is 5.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.04 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -83.0%.
The range of the Relative Valuation is 2.98 - 8.01 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 21.0x | 19.1x |
| Forward P/E multiples | 18.8x - 27.0x | 22.9x |
| Fair Price | 2.98 - 8.01 | 5.46 |
| Upside | -90.7% - -75.0% | -83.0% |
| Date | P/E |
| 2025-09-11 | 85.19 |
| 2025-09-10 | 83.52 |
| 2025-09-09 | 83.98 |
| 2025-09-08 | 84.98 |
| 2025-09-05 | 84.53 |
| 2025-09-04 | 83.69 |
| 2025-09-03 | 83.22 |
| 2025-09-02 | 78.03 |
| 2025-08-29 | 76.98 |
| 2025-08-28 | 76.00 |
| 2025-08-27 | 74.98 |
| 2025-08-26 | 74.22 |
| 2025-08-25 | 74.88 |
| 2025-08-22 | 77.28 |
| 2025-08-21 | 75.51 |
| 2025-08-20 | 74.30 |
| 2025-08-19 | 73.28 |
| 2025-08-18 | 72.78 |
| 2025-08-15 | 73.70 |
| 2025-08-14 | 72.88 |
| 2025-08-13 | 73.14 |
| 2025-08-12 | 71.18 |
| 2025-08-11 | 69.26 |
| 2025-08-08 | 70.10 |
| 2025-08-07 | 73.20 |
| 2025-08-06 | 72.70 |
| 2025-08-05 | 74.53 |
| 2025-08-04 | 75.37 |
| 2025-08-01 | 91.91 |
| 2025-07-31 | 93.17 |
| 2025-07-30 | 95.19 |
| 2025-07-29 | 92.72 |
| 2025-07-28 | 94.45 |
| 2025-07-25 | 96.84 |
| 2025-07-24 | 95.87 |
| 2025-07-23 | 98.68 |
| 2025-07-22 | 98.08 |
| 2025-07-21 | 98.21 |
| 2025-07-18 | 99.49 |
| 2025-07-17 | 102.85 |
| 2025-07-16 | 101.93 |
| 2025-07-15 | 99.62 |
| 2025-07-14 | 102.14 |
| 2025-07-11 | 97.33 |
| 2025-07-10 | 98.86 |
| 2025-07-09 | 99.52 |
| 2025-07-08 | 93.46 |
| 2025-07-07 | 94.43 |
| 2025-07-03 | 96.37 |
| 2025-07-02 | 95.24 |